International e- Journal of Nanotechnology and Nano Medicine (IEJNN) is a broad-spectrum journal helps to promote the emerging interdisciplinary field of nanotechnology and Nano medicine.
International e- journal of nanotechnology and Nano medicine is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to Nanoscience and nanotechnology in the life sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.
The potential scope of Nanomedicine is broad, and we expect it to eventually involve all aspects of medicine. Sub-categories include synthesis, bioavailability, and bio distribution of Nanomedicines, delivery, pharmacodynamics, and pharmacokinetics of nanomedicines, imaging, diagnostics, improved therapeutics, innovative biomaterials, interactions of nanomaterials with cells, tissues, and living organisms, regenerative medicine, public health, toxicology, point of care monitoring, nutrition, nonmedical devices, prosthetics, biomimetics, and bioinformatics.
Article formats include Communications, Original Articles, Reviews, Perspectives, Technical and Commercialization Notes, and Letters to the Editor. Papers presenting information of a multidisciplinary nature that would not be suitable for publication in a journal devoted to a single discipline are particularly welcome.
We do accept:
1) Short reports - 2-5 page papers where an author can present either an idea with theoretical background but has not yet completed the research needed for a complete paper or preliminary data.
2) Book reviews - Comments and critiques.
All manuscripts will be peer-reviewed with experts in the relevant fields and will be published within 2 months of submission if accepted. Also, systematic reviews of clinical and basic research, as well as clinical practice guidelines, are especially welcome.
All the content published with us is open and freely accessible under the guidelines of Creative Common Attribution License.